Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 22,072 | 23,827 | 26,911 | 26,848 | 24,830 |
| Operating Income | -22,072 | -23,827 | -26,911 | -26,848 | -24,830 |
| Interest Expense | 0 | 0 | -5 | 5 | 8 |
| Other Income | 172 | 173 | 304 | 2,531 | 3,812 |
| Pre-tax Income | -21,900 | -23,654 | -26,601 | -24,322 | -21,025 |
| Net Income Continuous | -21,900 | -23,654 | -26,601 | -24,322 | -21,025 |
| Net Income | $-21,900 | $-23,654 | $-26,601 | $-24,322 | $-21,025 |
| EPS Basic Total Ops | -4.40 | -6.61 | -12.01 | -15.02 | -16.52 |
| EPS Basic Continuous Ops | -4.40 | -6.70 | -11.97 | -15.07 | -16.55 |
| EPS Diluted Total Ops | -4.40 | -6.61 | -12.01 | -15.02 | -16.52 |
| EPS Diluted Continuous Ops | -4.40 | -6.70 | -11.97 | -15.07 | -16.55 |
| EBITDA(a) | $-21,652 | $-23,777 | $-26,855 | $-26,770 | $-24,776 |